Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10002492 | 0.97 | USP2 (0.32) | ALDH1A1SMN1; SMN2TSHRLMNAUSP2 | |
| SCHEMBL10332169 | 0.92 | — | — | |
| SCHEMBL57071 | 0.87 | — | — | |
| SCHEMBL22261571 | 0.82 | CYP2C19 (0.39) | ALDH1A1SMN1; SMN2TSHRLMNAUSP2 | |
| SCHEMBL932855 | 0.82 | CYP2C19 (0.39) | ALDH1A1SMN1; SMN2TSHRLMNAUSP2 | |
| SCHEMBL4351644 | 0.80 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2TSHRLMNAUSP2 | |
| SCHEMBL15822628 | 0.80 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2TSHRLMNAUSP2 | |
| SCHEMBL15822631 | 0.80 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2TSHRLMNAUSP2 | |
| SCHEMBL14831209 | 0.80 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2TSHRLMNAUSP2 | |
| SCHEMBL15821897 | 0.80 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2TSHRLMNAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009001127-A1 | CYANOCYCLOPROPYLCARBOXAMIDES AS CATHEPSIN INHIBITORS | ASTRAZENECA AB (SE) | 2008-12-31 | — | — | WO | disclosed |